STATE OF OVARIAN RESERVE UNDER THE CONDITIONS OF COMORBID PATHOLOGY OF THE MAMMARY GLANDS AND ENDOMETRIOSIS

Authors

DOI:

https://doi.org/10.11603/24116-4944.2022.2.13453

Keywords:

endometriosis, laparoscopic method, oncomarker CA 125, ovarian reserve, mammary gland dysfunction

Abstract

The aim of the study – to determine the ovarian reserve and dynamics of CA-125 in patients with benign mammary gland pathology and endometriosis (EM) before surgical treatment.

Materials and Methods. 120 women aged 23 to 35 were included in the study. The control group consisted of 25 healthy non-pregnant women. All patients surveyed in the first stage was performed surgery.

Results and Discussion. Prevalence of autoimmune thyroiditis (38 %) is dominated by hypothyroidism (13 %) and hyperthyroidism (12 %).Dysmenorrhea bothered 36 % of patients, 19 % of patients complained of sleep disturbance, periodic headache – 24 %, feeling of fatigue – 29 %, hair loss – 18 %, dry skin – 12 %, swelling of the lower extremities – 18 %, weight gain – 42 %, transferred inflammatory diseases of the lower part of the genital tract in almost 43 % of patients, laparoscopic interventions for ovarian endometriosis in 68 %, myomectomy – in 9 %, primary infertility occurred in 72 % of women and secondary infertility – in 28 % of patients. Patients included in this study, the surveys were conducted, which included a thorough history, physical examination, staging process during laparoscopic interventions and determination of CA-125 and ovariane reserve.

Conclusions. Indicator of CA-125E and ovariane reserve are an effective marker of activity endometriosis process. We found that dyshormonal disorders of the mammary glands most often have accompanying dyshormonal pathology of the thyroid gland, endometriosis and infertility, which are associated with impaired reproductive function.

References

Ishenko, A.I., Kudrina, E.A., & Abdullaeva, U.A. (2006). Effektivnost kombinirovannogo lecheniya naruzhnogo endometrioza s sindromom hronicheskih tazovyh bolej s ispolzovaniem agonista gonadotropin-rilizing gormona Dekapeptil-depo [The effectiveness of combined treatment of external endometriosis with chronic pelvic pain syndrome using the gonadotropin-releasing hormone agonist Decapeptyl-depot]. Zhinochyi likar – Female Doctor, 6(8), 8-11 [in Russian].

Vinatier, D., Cosson, M., & Dufour, P. (2000). Is endometriosis anendometrial disease? Eur. J. Obstet. Gynecol. Reprod. Biol., 91(2), 113-125.

Ulcova Galova Z. (2002). Endometriosis in reproductive immunology. Am. J. Reprod. Immunol, 5, 269-274.

Denny E. (2004). Women's experience of endometriosis. J. Adv. Nurs., 46(6), 641-648.

(2013). Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). Diagnostik und Therapie der Endometriose. AWMF Guidelines, 015/045.

Fernandez, I., Reid, C., & Dziurawiec, S.M. (2006). Living with endometriosis: The perspective of male partners. J. Psychosom. Res., 61(4), 433-438.

Hickey, M., & Ballard, K., & Farquhar, C. (2014). Endometriosis. BMJ, 348.

Hughes, E., Brown, J., Collins, J.J., Farquhar, C., Fedorkow, D.M., & Vandekerckhove, P. (2007). Ovulation suppression for endometriosis. Cochrane Database Sys. Rev., 3.

Seleh, A., & Tulandi, T. (1999). Reoperation after laporocopic treatectoment of ovarian endometriomas by excision and by fenestration. Fertil. Steril., 72(2), 322-324.

Stratton, P., & Berkley, K.J. (2011). Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum. Reprod. Update, 17, 327-324

Tseng, J.F., Ryan, I.P., & Milam, T.D. (1996). lnterleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J. Clin. Endocrinol. Metab., 81, 1118-1122.

Treatment of pelvic pain associated with endometriosis (2008). Practice Committee of the American Society for Reproductive Medicine. Fertil. Steril., 90, 260-269.

Vercellini, P. (2003). Progestogens for endometriosis: forward to the past. Hum. Reprod. Update, 9(4), 387-396.

Xue, Q., Lin, Z., & Cheng, Y.H. (2007). Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol., 77, 681-687.

Zanetta, G., Lissoni, A., Dalla Valle, C., Trio, D., & Pittelli, M. et al. (1995). Ultrasound-guided aspiration of endometriomas: possible applications and limitations. Fertil. Steril, 64(4), 709-713.

Hickey, M., & Ballard, K., & Farquhar, C. (2014). Endometriosis. BMJ, 348.

Stratton, P., & Berkley, K.J. (2011). Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum. Reprod. Update, 17(3), 324-327.

Visser, J.A., Schipper, I., & Laven, J.S.E. (2012). Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat. Rev. Endocrinol., 6, 331-341.

Published

2022-12-15

How to Cite

Boychuk А. V., Miklashevska, O. A., Yakymchuk, Y. B., & Yakymchuk, O. M. (2022). STATE OF OVARIAN RESERVE UNDER THE CONDITIONS OF COMORBID PATHOLOGY OF THE MAMMARY GLANDS AND ENDOMETRIOSIS . Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 71–75. https://doi.org/10.11603/24116-4944.2022.2.13453

Issue

Section

OBSTETRICS AND GYNECOLOGY